Get the tools used by (smart)2 investors.

EBIT Forecast Median Consensus for AstraZeneca PLC

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AZN: AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso...

- GBP
Price
GBP
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on AstraZeneca PLC's EBIT Forecast Median Consensus:

Dec 2026Dec 2028Dec 2030Dec 2032Dec 203415 B20 B25 B30 B35 B

Performance Summary
  • AstraZeneca's ebit forecast median consensus for the next fiscal year is 14.332 billion
  • AstraZeneca's ebit forecast median consensus is expected to average 17.727 billion over the next 5 fiscal years.
  • AstraZeneca's is expected to deliver median ebit forecast median consensus of 17.706 billion over the next 5 fiscal years.

How does AstraZeneca's EBIT Forecast Median Consensus benchmark against competitors?

Hide this widget

We've identified the following companies as similar to AstraZeneca PLC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: EBIT Forecast Median Consensus

Hide this widget
ebit_proj_median_raw
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBIT Forecast Median Consensus in the forecast category include:

  • Consensus EBIT, Actual - Reported EBIT including any adjustments for unusual items proposed by management. This metric is useful for analyst forecast vs actual analysis since deciding which add backs are truly "unusual" is subjective. Consider using "ebit" slug instead for other analysis.
  • AFFO Forecast Revision Date - The date/time at which the current consensus estimate of forecasted AFFO was last updated.
  • Unlevered FCF Forecast Margin - Forecasted unlevered free cash flow as a percent of forecasted revenue.
  • EPS Forecast Low Consensus - The lowest EPS Forecast submitted by any analyst for the company.
View Full List

Search for metric or datapoint

EBIT Forecast Median Consensus

The median EBIT Forecast submitted by any analyst for the company.

Definition of EBIT Forecast Median Consensus

Hide this widget
The median EBIT Forecast submitted by any analyst for the company.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-174.1 M775.9 M1.726 B3.482 B0400800

The chart above depicts the distribution of ebit forecast median consensus for companies operating in the Healthcare sector in the Developed economic region. Over 1,835 companies were considered in this analysis, and 1,766 had meaningful values. The average ebit forecast median consensus of companies in the sector is 76.813 M with a standard deviation of 378.2 M.

AstraZeneca PLC's EBIT Forecast Median Consensus of 14.332 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

EBIT Forecast Median Consensus In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,840
Included Constituents1,766
Min-252.5 M
Max3.461 B
Median-4.791 M
Mean76.813 M
Standard Deviation378.2 M

You can find companies with similar ebit forecast median consensus using this stock screener.

All rights reserved. Terms Of Use